Napredna pretraga

Pregled bibliografske jedinice broj: 1035412

Measuring empowerment in EmERGE mHealth platform users: a descriptive analysis of interim data


Bremner, S; Jones, C; Leon, A; Begovac, Josip; Apers, L; Borges, M; Zekan, Šime; Teofilo, E; Garcia, F; Whetham, J.
Measuring empowerment in EmERGE mHealth platform users: a descriptive analysis of interim data // Hiv medicine, 20 (2019), Suppl.9; 211-211 (međunarodna recenzija, ostalo, znanstveni)


Naslov
Measuring empowerment in EmERGE mHealth platform users: a descriptive analysis of interim data

Autori
Bremner, S ; Jones, C ; Leon, A ; Begovac, Josip ; Apers, L ; Borges, M ; Zekan, Šime ; Teofilo, E ; Garcia, F ; Whetham, J.

Izvornik
Hiv medicine (1464-2662) 20 (2019), Suppl.9; 211-211

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, ostalo, znanstveni

Ključne riječi
EmERGE mHealth platform ; Users

Sažetak
Purpose: To assess the potential effectiveness of a co-designed reduced visit pathway of care for individuals living with stable HIV in terms of empowerment (which encapsulates patient confidence, skills and knowledge to self-manage health and care). Methods: People living with stable HIV across five diverse clinical sites in Europe were invited to take part in the EmERGE study - whereby individuals are seen once, instead of twice, a year by their clinician - with their interim visit supported via an mHealth platform. We report here on preliminary data on the primary outcome, empowerment, measured by PAM-13 (Patient Activation Measure-13) at baseline (M0) and 12 months (M12). Results: PAM-13 was available on 2112/2251 (93.8%) of participants at M0 and 1026/1439 (72.3%) at M12. The overall proportion of participants at low activation Levels (L) 1&2 was 12.4% (261/2112) at baseline, ranging from 10.5% in Antwerp to 13.5% in Zagreb. At M12, the overall proportion was 14.1% (145/1026), ranging from 9.0% in Zagreb to 17.1% in Barcelona. Change in activation from L1&2 at baseline to L3&4 at M12 was achieved by 63/101 (62.4%) L1&2 baseline participants whilst 93/891 (10.4%) of baseline participants at L3&4 had dropped to L1&2 by M12 ; 836/992 (84.3%) did not switch between L1&2 and L3&4. The distribution of participants across each of the four levels of PAM-13 was similar across sites at baseline with≥86% of participants with the highest levels of activation. At four out of five sites, the proportion at L3&4 is currently lower at M12 than at M0. Conclusions: The majority of participants had a high level of empowerment at baseline. Over 60% of respondents in the lowest categories of PAM-13 (L1&2) at baseline shifted to L3&4 in M12. The proportion of participants at low activation levels was similar between sites. Follow-up continues until October 2019.

Izvorni jezik
Engleski



POVEZANOST RADA


Projekt / tema
108-1080116-0098 - Epidemiološka i klinička obilježja zaraze HIV-om u Hrvatskoj (Josip Begovac, )

Ustanove
Medicinski fakultet, Zagreb

Profili:

Avatar Url Josip Begovac (autor)

Citiraj ovu publikaciju

Bremner, S; Jones, C; Leon, A; Begovac, Josip; Apers, L; Borges, M; Zekan, Šime; Teofilo, E; Garcia, F; Whetham, J.
Measuring empowerment in EmERGE mHealth platform users: a descriptive analysis of interim data // Hiv medicine, 20 (2019), Suppl.9; 211-211 (međunarodna recenzija, ostalo, znanstveni)
Bremner, S., Jones, C., Leon, A., Begovac, J., Apers, L., Borges, M., Zekan, Š., Teofilo, E., Garcia, F. & Whetham, J. (2019) Measuring empowerment in EmERGE mHealth platform users: a descriptive analysis of interim data. Hiv medicine, 20 (Suppl.9), 211-211.
@article{article, year = {2019}, pages = {211-211}, keywords = {EmERGE mHealth platform, Users}, journal = {Hiv medicine}, volume = {20}, number = {Suppl.9}, issn = {1464-2662}, title = {Measuring empowerment in EmERGE mHealth platform users: a descriptive analysis of interim data}, keyword = {EmERGE mHealth platform, Users} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE